MONTHS

Summary of Financial Performance

Three months ended June 30, Six months ended June 30,

(US$?000) 2007

2006

Change

(%)

2007 2006 Change

(%)

Net sales

27,846 24,368 14.3 51,416 44,819 14.7

Gross profit

19,138 17,589 8.8 34,761 32,367 7.4

Operating expenses:

Selling, general and

administrative

(11,925) (9,643) (23,155) (18,868)

Research and development (388) (379) (603) (794)

Amortisation of intangible assets

(161) (14) (220) (28)

Total operating income

6,664 7,553 (11.8) 10,783 12,677 (14.9)

Net income before income

taxes, minority interests and

share of net earnings of

associate

6,934 8,204 (15.5) 11,334 13,386 (15.3)

Income tax expense (770) (741) (1,337) (1,338)

Minority interests (231) 218 (140) 310

Share of net earnings of

associate

- 195 - 168

Net income excluding noncash

stock compensation

charge

5,933 7,876 (24.7) 9,857 12,526 (21.3)

Non-cash stock compensation

charge

(444) (404) (879) (718)

Net income 5,489 7,472 (26.5) 8,978 11,808 (24.0)

Earnings per Share (EPS)

Three months ended June 30, Six months ended June 30,

(U.S. cents)

Before non-cash stock

compensation charge

Diluted EPS, including shares

to be issued for LMA

PacMed2007 2006 2007 2006(1) 1.021 1.356 1.697 2.156(2) 1.009 1.340 1.677 2.131

Announcement to the Singapore Exchange

GERMAN PATENT OFFICE UPHOLDS LMA?S IP AGAINST AMBU

CHALLENGE

Mainboard-listed LMA International NV (?LMA?), the global leader in the development

and marketing of the LMA? range of supraglottic airway management devices, is

pleased to announce that the German Patent Office has upheld its intellectual property

right ? German Utility Model DE 299 24 738 ? against a challenge by Danish competitor

Ambu A/S (?Ambu?). This IP right protects LMA?s invention of a reinforced tip on

supraglottic airway devices.

In a separate court action, LMA?s wholly-owned subsidiary, LMA Deutschland GmbH,

had earlier obtained a judgment in Germany that Ambu?s airway devices infringe LMA?s

invention. LMA is seeking ?3.1 million in damages from Ambu for its infringement in

Germany. The decision of the German Patent Office ensures that LMA?s damages claim

action will proceed. That action is currently scheduled to be heard in August 2007.

LMA has additional patent infringement actions pending against Ambu in France and the

Netherlands to protect the same invention and currently has the legal right to commence

similar actions in other markets.

LMA expects Ambu to appeal the German Patent Office?s decision, as it has appealed